Global α-blocker Market Professional Survey Report 2019
Table of Contents
Executive Summary
1 Industry Overview of α-blocker
- 1.1 Definition of α-blocker
- 1.2 α-blocker Segment by Type
- 1.2.1 Global α-blocker Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 Non-selective Antagonists
- 1.2.3 Selective Antagonists
- 1.3 α-blocker Segment by Applications
- 1.3.1 Global α-blocker Consumption Comparison by Applications (2014-2025)
- 1.3.2 Hypertension
- 1.3.3 Raynaud's Disease
- 1.3.4 Erectile Dysfunction
- 1.4 Global α-blocker Overall Market
- 1.4.1 Global α-blocker Revenue (2014-2025)
- 1.4.2 Global α-blocker Production (2014-2025)
- 1.4.3 North America α-blocker Status and Prospect (2014-2025)
- 1.4.4 Europe α-blocker Status and Prospect (2014-2025)
- 1.4.5 China α-blocker Status and Prospect (2014-2025)
- 1.4.6 Japan α-blocker Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia α-blocker Status and Prospect (2014-2025)
- 1.4.8 India α-blocker Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of α-blocker
- 2.3 Manufacturing Process Analysis of α-blocker
- 2.4 Industry Chain Structure of α-blocker
3 Development and Manufacturing Plants Analysis of α-blocker
- 3.1 Capacity and Commercial Production Date
- 3.2 Global α-blocker Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of α-blocker
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 α-blocker Production and Capacity Analysis
- 4.2 α-blocker Revenue Analysis
- 4.3 α-blocker Price Analysis
- 4.4 Market Concentration Degree
5 α-blocker Regional Market Analysis
- 5.1 α-blocker Production by Regions
- 5.1.1 Global α-blocker Production by Regions
- 5.1.2 Global α-blocker Revenue by Regions
- 5.2 α-blocker Consumption by Regions
- 5.3 North America α-blocker Market Analysis
- 5.3.1 North America α-blocker Production
- 5.3.2 North America α-blocker Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America α-blocker Import and Export
- 5.4 Europe α-blocker Market Analysis
- 5.4.1 Europe α-blocker Production
- 5.4.2 Europe α-blocker Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe α-blocker Import and Export
- 5.5 China α-blocker Market Analysis
- 5.5.1 China α-blocker Production
- 5.5.2 China α-blocker Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China α-blocker Import and Export
- 5.6 Japan α-blocker Market Analysis
- 5.6.1 Japan α-blocker Production
- 5.6.2 Japan α-blocker Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan α-blocker Import and Export
- 5.7 Southeast Asia α-blocker Market Analysis
- 5.7.1 Southeast Asia α-blocker Production
- 5.7.2 Southeast Asia α-blocker Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia α-blocker Import and Export
- 5.8 India α-blocker Market Analysis
- 5.8.1 India α-blocker Production
- 5.8.2 India α-blocker Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India α-blocker Import and Export
6 α-blocker Segment Market Analysis (by Type)
- 6.1 Global α-blocker Production by Type
- 6.2 Global α-blocker Revenue by Type
- 6.3 α-blocker Price by Type
7 α-blocker Segment Market Analysis (by Application)
- 7.1 Global α-blocker Consumption by Application
- 7.2 Global α-blocker Consumption Market Share by Application (2014-2019)
8 α-blocker Major Manufacturers Analysis
- 8.1 Pfizer
- 8.1.1 Pfizer α-blocker Production Sites and Area Served
- 8.1.2 Pfizer Product Introduction, Application and Specification
- 8.1.3 Pfizer α-blocker Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
- 8.2 Novartis
- 8.2.1 Novartis α-blocker Production Sites and Area Served
- 8.2.2 Novartis Product Introduction, Application and Specification
- 8.2.3 Novartis α-blocker Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.2.4 Main Business and Markets Served
- 8.3 Merck
- 8.3.1 Merck α-blocker Production Sites and Area Served
- 8.3.2 Merck Product Introduction, Application and Specification
- 8.3.3 Merck α-blocker Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.3.4 Main Business and Markets Served
- 8.4 Astra Zeneca
- 8.4.1 Astra Zeneca α-blocker Production Sites and Area Served
- 8.4.2 Astra Zeneca Product Introduction, Application and Specification
- 8.4.3 Astra Zeneca α-blocker Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.4.4 Main Business and Markets Served
- 8.5 Jhonson and Johnson
- 8.5.1 Jhonson and Johnson α-blocker Production Sites and Area Served
- 8.5.2 Jhonson and Johnson Product Introduction, Application and Specification
- 8.5.3 Jhonson and Johnson α-blocker Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.5.4 Main Business and Markets Served
- 8.6 Eli Lilly
- 8.6.1 Eli Lilly α-blocker Production Sites and Area Served
- 8.6.2 Eli Lilly Product Introduction, Application and Specification
- 8.6.3 Eli Lilly α-blocker Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.6.4 Main Business and Markets Served
- 8.7 Sanofi
- 8.7.1 Sanofi α-blocker Production Sites and Area Served
- 8.7.2 Sanofi Product Introduction, Application and Specification
- 8.7.3 Sanofi α-blocker Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.7.4 Main Business and Markets Served
- 8.8 Bristol-Myers Squibb
- 8.8.1 Bristol-Myers Squibb α-blocker Production Sites and Area Served
- 8.8.2 Bristol-Myers Squibb Product Introduction, Application and Specification
- 8.8.3 Bristol-Myers Squibb α-blocker Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.8.4 Main Business and Markets Served
- 8.9 Bayer
- 8.9.1 Bayer α-blocker Production Sites and Area Served
- 8.9.2 Bayer Product Introduction, Application and Specification
- 8.9.3 Bayer α-blocker Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.9.4 Main Business and Markets Served
- 8.10 GSK
- 8.10.1 GSK α-blocker Production Sites and Area Served
- 8.10.2 GSK Product Introduction, Application and Specification
- 8.10.3 GSK α-blocker Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.10.4 Main Business and Markets Served
- 8.11 Teva Pharmaceutical
9 Development Trend of Analysis of α-blocker Market
- 9.1 Global α-blocker Market Trend Analysis
- 9.1.1 Global α-blocker Market Size (Volume and Value) Forecast 2019-2025
- 9.2 α-blocker Regional Market Trend
- 9.2.1 North America α-blocker Forecast 2019-2025
- 9.2.2 Europe α-blocker Forecast 2019-2025
- 9.2.3 China α-blocker Forecast 2019-2025
- 9.2.4 Japan α-blocker Forecast 2019-2025
- 9.2.5 Southeast Asia α-blocker Forecast 2019-2025
- 9.2.6 India α-blocker Forecast 2019-2025
- 9.3 α-blocker Market Trend (Product Type)
- 9.4 α-blocker Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 α-blocker Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
α-blockers or α-adrenoreceptor antagonists, are a class of pharmacological agents that act as antagonists on α-adrenergic receptors (α-adrenoceptors).
The global α-blocker market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on α-blocker volume and value at global level, regional level and company level. From a global perspective, this report represents overall α-blocker market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of α-blocker in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their α-blocker manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Pfizer
Novartis
Merck
Astra Zeneca
Jhonson and Johnson
Eli Lilly
Sanofi
Bristol-Myers Squibb
Bayer
GSK
Teva Pharmaceutical
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Non-selective Antagonists
Selective Antagonists
Segment by Application
Hypertension
Raynaud's Disease
Erectile Dysfunction